United States · Bill · HR
H.R. 1683 (118th)
Generic Animal Drug Advancement Act
Introduced
21 March 2023
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
27 May 2025
Summary
Generic Animal Drug Advancement Act This bill allows for the approval and corresponding labeling of generic animal drugs that are bioequivalent to another approved drug with respect to at least one species, rather than with respect to all of the same species. (Animal drugs are drugs that are intended for animals other than humans (e.g., pets and livestock). Animal drugs must be approved by the Food and Drug Administration before they may be offered on the commercial market.)
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 21 March 2023
Introduced in House (PDF)
Introduced in House · EN · 21 March 2023
Introduced in House
summary · EN · 21 March 2023
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/118th-congress/house-bill/1683
- Open data entity: https://api.congress.gov/v3/bill/118/hr/1683